Effects of mission duration on neuroimmune responses in astronauts.
暂无分享,去创建一个
[1] A. Fauci,et al. Alternate-day prednisone therapy and human lymphocyte subpopulations. , 1975, The Journal of clinical investigation.
[2] P J Mills,et al. Peripheral Leukocyte Subpopulations and Catecholamine Levels in Astronauts as a Function of Mission Duration , 2001, Psychosomatic medicine.
[3] G Sonnenfeld,et al. Changes in the immune system during and after spaceflight. , 1997, Advances in space biology and medicine.
[4] D. Pierson,et al. Elevated Stress Hormone Levels Relate to Epstein-Barr Virus Reactivation in Astronauts , 2001, Psychosomatic medicine.
[5] D. Mason,et al. Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. , 1996, Journal of immunology.
[6] G Sonnenfeld,et al. Immune Responses in Space Flight , 1998, International journal of sports medicine.
[7] G. Taylor. Immune changes during short‐duration missions , 1993, Journal of leukocyte biology.
[8] D. Pierson,et al. Reactivation and shedding of cytomegalovirus in astronauts during spaceflight. , 2000, The Journal of infectious diseases.
[9] Daniel L. Feeback,et al. Leukocyte subsets and neutrophil function after short‐term spaceflight , 1999, Journal of leukocyte biology.
[10] D. Papanicolaou,et al. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. , 1996, Proceedings of the Association of American Physicians.
[11] M. Schedlowski,et al. Catecholamine-Induced Leukocytosis: Early Observations, Current Research, and Future Directions , 1996, Brain, Behavior, and Immunity.
[12] C. Akdis,et al. Glucocorticoids inhibit human antigen‐specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro , 1997, European journal of immunology.
[13] C S Leach. Biochemical and hematologic changes after short-term space flight. , 1992, Microgravity quarterly : MGQ.
[14] Daniel L. Feeback,et al. Immune responses and latent herpesvirus reactivation in spaceflight. , 2001, Aviation, space, and environmental medicine.
[15] D. Umetsu,et al. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. , 1997, Journal of immunology.
[16] A. Fauci,et al. Corticosteroid‐Mediated Immunoregulation in Man , 1982, Immunological reviews.
[17] A. Fauci,et al. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. , 1976, Annals of internal medicine.
[18] Kehrl Jh,et al. The clinical use of glucocorticoids. , 1983 .
[19] T P Stein,et al. Nutrition and muscle loss in humans during spaceflight. , 1999, Advances in space biology and medicine.
[20] A Cogoli,et al. Cellular immunity in cosmonauts during long duration spaceflight on board the orbital MIR station. , 1994, Aviation, space, and environmental medicine.
[21] E. Gelfand,et al. In vivo effects of glucocorticoids on IgE production. , 1994, The Journal of allergy and clinical immunology.
[22] D. Pierson,et al. Incidence of Epstein-Barr virus in astronaut saliva during spaceflight. , 1999, Aviation, space, and environmental medicine.
[23] C. Sams,et al. The role of psychoneuroendocrine factors on spaceflight‐induced immunological alterations , 1993, Journal of leukocyte biology.
[24] J I Leonard,et al. Regulation of body fluid compartments during short-term spaceflight. , 1996, Journal of applied physiology.
[25] L S Neale,et al. Alteration in human mononuclear leucocytes following space flight. , 1992, Immunology.
[26] G R Taylor,et al. Immunological analyses of U.S. Space Shuttle crewmembers. , 1986, Aviation, space, and environmental medicine.
[27] A. Fauci,et al. The clinical use of glucocorticoids. , 1983, Annals of allergy.